A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
Penn Medicine used an artificial intelligence tool to find a treatment that aided in saving the life of a patient with ...
The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...
The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 medications to discover one treatment which may work.
Detailed in a new paper published in NEJM, a group led by researchers at the Perelman School of Medicine at the University of Pennsylvania used an AI technique called machine learning to determine ...
Objectives: The aim of this study is to illustrate the long-term efficacy and safety of etanercept (ETN) and adalimumab (ADA) as first-line therapy in a monocentric cohort of JIA patients. Methods: ...
aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...